Arrowhead Pharmaceuticals Inc. (0HI3)
LSE
Closed
Aug 21, 2026
Day's Range
86.0652 wk Range
19.85Overview - 0HI3 - Arrowhead Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
12.07B
Price / Book
‪26.12‬
EV / EBITDA
‪-60.17‬
Profitability
Profit Margin
‪-47.79%‬
Operating Margin
‪-226.02%‬
Return on Assets
‪-8.10%‬
Return on Equity
‪-55.20%‬
Ownership
Shares Outstanding
88.02M
Float
122.45M
Held by Insiders
‪3.66%‬
Held by Institutions
‪85.57%‬
Price stats
Beta
‪1.29‬
50-Day Avg
‪32.83‬
200-Day Avg
‪31.06‬
Market Cap - 0HI3 - Arrowhead Pharmaceuticals Inc.
Peers - 0HI3 - Arrowhead Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0HI3LSEArrowhead Pharmaceuticals Inc.7.58BMarket Cap+75.88%52-week change—P/E (Trailing)‪-47.79%‬Profit Margin
- 0MGBLSEGenmab A/S173.69BMarket Cap+27.59%52-week change30.65P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated140.34BMarket Cap+29.12%52-week change0.58P/E (Trailing)‪34.99%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.90.49BMarket Cap+31.55%52-week change0.12P/E (Trailing)‪27.86%‬Profit Margin
- 0A45LSEModerna, Inc.72.10BMarket Cap+82.56%52-week change55.34P/E (Trailing)‪11.32%‬Profit Margin
- 0QW0LSEargenx SE52.61BMarket Cap+34.75%52-week change42.42P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA44.92BMarket Cap+9.47%52-week change128.71P/E (Trailing)‪6.45%‬Profit Margin
Profile Summary - 0HI3 - Arrowhead Pharmaceuticals Inc.
About
Arrowhead Pharmaceuticals is a biotechnology company focused on developing innovative medicines for intractable diseases. The company specializes in RNA interference (RNAi) therapeutics, a cutting-edge approach to treating genetic and metabolic disorders by targeting disease-causing proteins at the molecular level.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
